Global Amphotericin B Injection Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
Abelcet is a prescription medicine used to treat the symptoms of Systemic Fungal Infection
The global market for Amphotericin B Injection is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Amphotericin B Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Amphotericin B Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Amphotericin B Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Amphotericin B Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Amphotericin B Injection players cover Swiss Parenterals, Aspen Pharmacare, Health Biotech, Abbott Laboratories and Abraxis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Amphotericin B Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Amphotericin B Injection market, with both quantitative and qualitative data, to help readers understand how the Amphotericin B Injection market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Vial.
Market Segmentation:
The study segments the Amphotericin B Injection market and forecasts the market size by Dosage Strength (5Mg/Vial, 50Mg/Vial and 100Mg/Vial), by Application (Hospital, Clinic and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by dosage strength
Chapter 1: Scope of Amphotericin B Injection, Research Methodology, etc.
Chapter 2: Executive Summary, global Amphotericin B Injection market size (sales and revenue) and CAGR, Amphotericin B Injection market size by region, by dosage strength, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Amphotericin B Injection sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Amphotericin B Injection sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by dosage strength, and dosage strength.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Amphotericin B Injection market size forecast by region, by country, by dosage strength, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Swiss Parenterals, Aspen Pharmacare, Health Biotech, Abbott Laboratories, Abraxis, Astellas Pharma, Bluepharma, Bristol Myers Squibb and Cheplapharm Arzneimittel, etc.
Chapter 14: Research Findings and Conclusion
Abelcet is a prescription medicine used to treat the symptoms of Systemic Fungal Infection
The global market for Amphotericin B Injection is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Amphotericin B Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Amphotericin B Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Amphotericin B Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Amphotericin B Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Amphotericin B Injection players cover Swiss Parenterals, Aspen Pharmacare, Health Biotech, Abbott Laboratories and Abraxis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Amphotericin B Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Amphotericin B Injection market, with both quantitative and qualitative data, to help readers understand how the Amphotericin B Injection market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Vial.
Market Segmentation:
The study segments the Amphotericin B Injection market and forecasts the market size by Dosage Strength (5Mg/Vial, 50Mg/Vial and 100Mg/Vial), by Application (Hospital, Clinic and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by dosage strength
- 5Mg/Vial
- 50Mg/Vial
- 100Mg/Vial
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Swiss Parenterals
- Aspen Pharmacare
- Health Biotech
- Abbott Laboratories
- Abraxis
- Astellas Pharma
- Bluepharma
- Bristol Myers Squibb
- Cheplapharm Arzneimittel
- Clinigen Group
- Flagship Biotech
- Gilead Sciences
- Ind Swift Laboratories
- Kaliberr Labs
- Kwality Pharmaceuticals
Chapter 1: Scope of Amphotericin B Injection, Research Methodology, etc.
Chapter 2: Executive Summary, global Amphotericin B Injection market size (sales and revenue) and CAGR, Amphotericin B Injection market size by region, by dosage strength, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Amphotericin B Injection sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Amphotericin B Injection sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by dosage strength, and dosage strength.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Amphotericin B Injection market size forecast by region, by country, by dosage strength, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Swiss Parenterals, Aspen Pharmacare, Health Biotech, Abbott Laboratories, Abraxis, Astellas Pharma, Bluepharma, Bristol Myers Squibb and Cheplapharm Arzneimittel, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amphotericin B Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Amphotericin B Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Amphotericin B Injection by Country/Region, 2017, 2022 & 2028
2.2 Amphotericin B Injection Segment by Dosage Strength
2.2.1 5Mg/Vial
2.2.2 50Mg/Vial
2.2.3 100Mg/Vial
2.3 Amphotericin B Injection Sales by Dosage Strength
2.3.1 Global Amphotericin B Injection Sales Market Share by Dosage Strength (2017-2022)
2.3.2 Global Amphotericin B Injection Revenue and Market Share by Dosage Strength (2017-2022)
2.3.3 Global Amphotericin B Injection Sale Price by Dosage Strength (2017-2022)
2.4 Amphotericin B Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Amphotericin B Injection Sales by Application
2.5.1 Global Amphotericin B Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Amphotericin B Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Amphotericin B Injection Sale Price by Application (2017-2022)
3 GLOBAL AMPHOTERICIN B INJECTION BY COMPANY
3.1 Global Amphotericin B Injection Breakdown Data by Company
3.1.1 Global Amphotericin B Injection Annual Sales by Company (2020-2022)
3.1.2 Global Amphotericin B Injection Sales Market Share by Company (2020-2022)
3.2 Global Amphotericin B Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Amphotericin B Injection Revenue by Company (2020-2022)
3.2.2 Global Amphotericin B Injection Revenue Market Share by Company (2020-2022)
3.3 Global Amphotericin B Injection Sale Price by Company
3.4 Key Manufacturers Amphotericin B Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amphotericin B Injection Product Location Distribution
3.4.2 Players Amphotericin B Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR AMPHOTERICIN B INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Amphotericin B Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Amphotericin B Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Amphotericin B Injection Annual Revenue by Geographic Region
4.2 World Historic Amphotericin B Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Amphotericin B Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Amphotericin B Injection Annual Revenue by Country/Region
4.3 Americas Amphotericin B Injection Sales Growth
4.4 APAC Amphotericin B Injection Sales Growth
4.5 Europe Amphotericin B Injection Sales Growth
4.6 Middle East & Africa Amphotericin B Injection Sales Growth
5 AMERICAS
5.1 Americas Amphotericin B Injection Sales by Country
5.1.1 Americas Amphotericin B Injection Sales by Country (2017-2022)
5.1.2 Americas Amphotericin B Injection Revenue by Country (2017-2022)
5.2 Americas Amphotericin B Injection Sales by Dosage Strength
5.3 Americas Amphotericin B Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amphotericin B Injection Sales by Region
6.1.1 APAC Amphotericin B Injection Sales by Region (2017-2022)
6.1.2 APAC Amphotericin B Injection Revenue by Region (2017-2022)
6.2 APAC Amphotericin B Injection Sales by Dosage Strength
6.3 APAC Amphotericin B Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Amphotericin B Injection by Country
7.1.1 Europe Amphotericin B Injection Sales by Country (2017-2022)
7.1.2 Europe Amphotericin B Injection Revenue by Country (2017-2022)
7.2 Europe Amphotericin B Injection Sales by Dosage Strength
7.3 Europe Amphotericin B Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amphotericin B Injection by Country
8.1.1 Middle East & Africa Amphotericin B Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Amphotericin B Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Amphotericin B Injection Sales by Dosage Strength
8.3 Middle East & Africa Amphotericin B Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amphotericin B Injection
10.3 Manufacturing Process Analysis of Amphotericin B Injection
10.4 Industry Chain Structure of Amphotericin B Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Amphotericin B Injection Distributors
11.3 Amphotericin B Injection Customer
12 WORLD FORECAST REVIEW FOR AMPHOTERICIN B INJECTION BY GEOGRAPHIC REGION
12.1 Global Amphotericin B Injection Market Size Forecast by Region
12.1.1 Global Amphotericin B Injection Forecast by Region (2023-2028)
12.1.2 Global Amphotericin B Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Amphotericin B Injection Forecast by Dosage Strength
12.7 Global Amphotericin B Injection Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Swiss Parenterals
13.1.1 Swiss Parenterals Company Information
13.1.2 Swiss Parenterals Amphotericin B Injection Product Offered
13.1.3 Swiss Parenterals Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Swiss Parenterals Main Business Overview
13.1.5 Swiss Parenterals Latest Developments
13.2 Aspen Pharmacare
13.2.1 Aspen Pharmacare Company Information
13.2.2 Aspen Pharmacare Amphotericin B Injection Product Offered
13.2.3 Aspen Pharmacare Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Aspen Pharmacare Main Business Overview
13.2.5 Aspen Pharmacare Latest Developments
13.3 Health Biotech
13.3.1 Health Biotech Company Information
13.3.2 Health Biotech Amphotericin B Injection Product Offered
13.3.3 Health Biotech Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Health Biotech Main Business Overview
13.3.5 Health Biotech Latest Developments
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Information
13.4.2 Abbott Laboratories Amphotericin B Injection Product Offered
13.4.3 Abbott Laboratories Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Abbott Laboratories Main Business Overview
13.4.5 Abbott Laboratories Latest Developments
13.5 Abraxis
13.5.1 Abraxis Company Information
13.5.2 Abraxis Amphotericin B Injection Product Offered
13.5.3 Abraxis Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Abraxis Main Business Overview
13.5.5 Abraxis Latest Developments
13.6 Astellas Pharma
13.6.1 Astellas Pharma Company Information
13.6.2 Astellas Pharma Amphotericin B Injection Product Offered
13.6.3 Astellas Pharma Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Astellas Pharma Main Business Overview
13.6.5 Astellas Pharma Latest Developments
13.7 Bluepharma
13.7.1 Bluepharma Company Information
13.7.2 Bluepharma Amphotericin B Injection Product Offered
13.7.3 Bluepharma Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Bluepharma Main Business Overview
13.7.5 Bluepharma Latest Developments
13.8 Bristol Myers Squibb
13.8.1 Bristol Myers Squibb Company Information
13.8.2 Bristol Myers Squibb Amphotericin B Injection Product Offered
13.8.3 Bristol Myers Squibb Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bristol Myers Squibb Main Business Overview
13.8.5 Bristol Myers Squibb Latest Developments
13.9 Cheplapharm Arzneimittel
13.9.1 Cheplapharm Arzneimittel Company Information
13.9.2 Cheplapharm Arzneimittel Amphotericin B Injection Product Offered
13.9.3 Cheplapharm Arzneimittel Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Cheplapharm Arzneimittel Main Business Overview
13.9.5 Cheplapharm Arzneimittel Latest Developments
13.10 Clinigen Group
13.10.1 Clinigen Group Company Information
13.10.2 Clinigen Group Amphotericin B Injection Product Offered
13.10.3 Clinigen Group Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Clinigen Group Main Business Overview
13.10.5 Clinigen Group Latest Developments
13.11 Flagship Biotech
13.11.1 Flagship Biotech Company Information
13.11.2 Flagship Biotech Amphotericin B Injection Product Offered
13.11.3 Flagship Biotech Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Flagship Biotech Main Business Overview
13.11.5 Flagship Biotech Latest Developments
13.12 Gilead Sciences
13.12.1 Gilead Sciences Company Information
13.12.2 Gilead Sciences Amphotericin B Injection Product Offered
13.12.3 Gilead Sciences Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Gilead Sciences Main Business Overview
13.12.5 Gilead Sciences Latest Developments
13.13 Ind Swift Laboratories
13.13.1 Ind Swift Laboratories Company Information
13.13.2 Ind Swift Laboratories Amphotericin B Injection Product Offered
13.13.3 Ind Swift Laboratories Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Ind Swift Laboratories Main Business Overview
13.13.5 Ind Swift Laboratories Latest Developments
13.14 Kaliberr Labs
13.14.1 Kaliberr Labs Company Information
13.14.2 Kaliberr Labs Amphotericin B Injection Product Offered
13.14.3 Kaliberr Labs Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Kaliberr Labs Main Business Overview
13.14.5 Kaliberr Labs Latest Developments
13.15 Kwality Pharmaceuticals
13.15.1 Kwality Pharmaceuticals Company Information
13.15.2 Kwality Pharmaceuticals Amphotericin B Injection Product Offered
13.15.3 Kwality Pharmaceuticals Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Kwality Pharmaceuticals Main Business Overview
13.15.5 Kwality Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amphotericin B Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Amphotericin B Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Amphotericin B Injection by Country/Region, 2017, 2022 & 2028
2.2 Amphotericin B Injection Segment by Dosage Strength
2.2.1 5Mg/Vial
2.2.2 50Mg/Vial
2.2.3 100Mg/Vial
2.3 Amphotericin B Injection Sales by Dosage Strength
2.3.1 Global Amphotericin B Injection Sales Market Share by Dosage Strength (2017-2022)
2.3.2 Global Amphotericin B Injection Revenue and Market Share by Dosage Strength (2017-2022)
2.3.3 Global Amphotericin B Injection Sale Price by Dosage Strength (2017-2022)
2.4 Amphotericin B Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Amphotericin B Injection Sales by Application
2.5.1 Global Amphotericin B Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Amphotericin B Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Amphotericin B Injection Sale Price by Application (2017-2022)
3 GLOBAL AMPHOTERICIN B INJECTION BY COMPANY
3.1 Global Amphotericin B Injection Breakdown Data by Company
3.1.1 Global Amphotericin B Injection Annual Sales by Company (2020-2022)
3.1.2 Global Amphotericin B Injection Sales Market Share by Company (2020-2022)
3.2 Global Amphotericin B Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Amphotericin B Injection Revenue by Company (2020-2022)
3.2.2 Global Amphotericin B Injection Revenue Market Share by Company (2020-2022)
3.3 Global Amphotericin B Injection Sale Price by Company
3.4 Key Manufacturers Amphotericin B Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amphotericin B Injection Product Location Distribution
3.4.2 Players Amphotericin B Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR AMPHOTERICIN B INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Amphotericin B Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Amphotericin B Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Amphotericin B Injection Annual Revenue by Geographic Region
4.2 World Historic Amphotericin B Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Amphotericin B Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Amphotericin B Injection Annual Revenue by Country/Region
4.3 Americas Amphotericin B Injection Sales Growth
4.4 APAC Amphotericin B Injection Sales Growth
4.5 Europe Amphotericin B Injection Sales Growth
4.6 Middle East & Africa Amphotericin B Injection Sales Growth
5 AMERICAS
5.1 Americas Amphotericin B Injection Sales by Country
5.1.1 Americas Amphotericin B Injection Sales by Country (2017-2022)
5.1.2 Americas Amphotericin B Injection Revenue by Country (2017-2022)
5.2 Americas Amphotericin B Injection Sales by Dosage Strength
5.3 Americas Amphotericin B Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amphotericin B Injection Sales by Region
6.1.1 APAC Amphotericin B Injection Sales by Region (2017-2022)
6.1.2 APAC Amphotericin B Injection Revenue by Region (2017-2022)
6.2 APAC Amphotericin B Injection Sales by Dosage Strength
6.3 APAC Amphotericin B Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Amphotericin B Injection by Country
7.1.1 Europe Amphotericin B Injection Sales by Country (2017-2022)
7.1.2 Europe Amphotericin B Injection Revenue by Country (2017-2022)
7.2 Europe Amphotericin B Injection Sales by Dosage Strength
7.3 Europe Amphotericin B Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amphotericin B Injection by Country
8.1.1 Middle East & Africa Amphotericin B Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Amphotericin B Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Amphotericin B Injection Sales by Dosage Strength
8.3 Middle East & Africa Amphotericin B Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amphotericin B Injection
10.3 Manufacturing Process Analysis of Amphotericin B Injection
10.4 Industry Chain Structure of Amphotericin B Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Amphotericin B Injection Distributors
11.3 Amphotericin B Injection Customer
12 WORLD FORECAST REVIEW FOR AMPHOTERICIN B INJECTION BY GEOGRAPHIC REGION
12.1 Global Amphotericin B Injection Market Size Forecast by Region
12.1.1 Global Amphotericin B Injection Forecast by Region (2023-2028)
12.1.2 Global Amphotericin B Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Amphotericin B Injection Forecast by Dosage Strength
12.7 Global Amphotericin B Injection Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Swiss Parenterals
13.1.1 Swiss Parenterals Company Information
13.1.2 Swiss Parenterals Amphotericin B Injection Product Offered
13.1.3 Swiss Parenterals Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Swiss Parenterals Main Business Overview
13.1.5 Swiss Parenterals Latest Developments
13.2 Aspen Pharmacare
13.2.1 Aspen Pharmacare Company Information
13.2.2 Aspen Pharmacare Amphotericin B Injection Product Offered
13.2.3 Aspen Pharmacare Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Aspen Pharmacare Main Business Overview
13.2.5 Aspen Pharmacare Latest Developments
13.3 Health Biotech
13.3.1 Health Biotech Company Information
13.3.2 Health Biotech Amphotericin B Injection Product Offered
13.3.3 Health Biotech Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Health Biotech Main Business Overview
13.3.5 Health Biotech Latest Developments
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Information
13.4.2 Abbott Laboratories Amphotericin B Injection Product Offered
13.4.3 Abbott Laboratories Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Abbott Laboratories Main Business Overview
13.4.5 Abbott Laboratories Latest Developments
13.5 Abraxis
13.5.1 Abraxis Company Information
13.5.2 Abraxis Amphotericin B Injection Product Offered
13.5.3 Abraxis Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Abraxis Main Business Overview
13.5.5 Abraxis Latest Developments
13.6 Astellas Pharma
13.6.1 Astellas Pharma Company Information
13.6.2 Astellas Pharma Amphotericin B Injection Product Offered
13.6.3 Astellas Pharma Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Astellas Pharma Main Business Overview
13.6.5 Astellas Pharma Latest Developments
13.7 Bluepharma
13.7.1 Bluepharma Company Information
13.7.2 Bluepharma Amphotericin B Injection Product Offered
13.7.3 Bluepharma Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Bluepharma Main Business Overview
13.7.5 Bluepharma Latest Developments
13.8 Bristol Myers Squibb
13.8.1 Bristol Myers Squibb Company Information
13.8.2 Bristol Myers Squibb Amphotericin B Injection Product Offered
13.8.3 Bristol Myers Squibb Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bristol Myers Squibb Main Business Overview
13.8.5 Bristol Myers Squibb Latest Developments
13.9 Cheplapharm Arzneimittel
13.9.1 Cheplapharm Arzneimittel Company Information
13.9.2 Cheplapharm Arzneimittel Amphotericin B Injection Product Offered
13.9.3 Cheplapharm Arzneimittel Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Cheplapharm Arzneimittel Main Business Overview
13.9.5 Cheplapharm Arzneimittel Latest Developments
13.10 Clinigen Group
13.10.1 Clinigen Group Company Information
13.10.2 Clinigen Group Amphotericin B Injection Product Offered
13.10.3 Clinigen Group Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Clinigen Group Main Business Overview
13.10.5 Clinigen Group Latest Developments
13.11 Flagship Biotech
13.11.1 Flagship Biotech Company Information
13.11.2 Flagship Biotech Amphotericin B Injection Product Offered
13.11.3 Flagship Biotech Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Flagship Biotech Main Business Overview
13.11.5 Flagship Biotech Latest Developments
13.12 Gilead Sciences
13.12.1 Gilead Sciences Company Information
13.12.2 Gilead Sciences Amphotericin B Injection Product Offered
13.12.3 Gilead Sciences Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Gilead Sciences Main Business Overview
13.12.5 Gilead Sciences Latest Developments
13.13 Ind Swift Laboratories
13.13.1 Ind Swift Laboratories Company Information
13.13.2 Ind Swift Laboratories Amphotericin B Injection Product Offered
13.13.3 Ind Swift Laboratories Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Ind Swift Laboratories Main Business Overview
13.13.5 Ind Swift Laboratories Latest Developments
13.14 Kaliberr Labs
13.14.1 Kaliberr Labs Company Information
13.14.2 Kaliberr Labs Amphotericin B Injection Product Offered
13.14.3 Kaliberr Labs Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Kaliberr Labs Main Business Overview
13.14.5 Kaliberr Labs Latest Developments
13.15 Kwality Pharmaceuticals
13.15.1 Kwality Pharmaceuticals Company Information
13.15.2 Kwality Pharmaceuticals Amphotericin B Injection Product Offered
13.15.3 Kwality Pharmaceuticals Amphotericin B Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Kwality Pharmaceuticals Main Business Overview
13.15.5 Kwality Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Amphotericin B Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Amphotericin B Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 5Mg/Vial
Table 4. Major Players of 50Mg/Vial
Table 5. Major Players of 100Mg/Vial
Table 6. Global Amphotericin B Injection Sales by Dosage Strength (2017-2022) & (Vial)
Table 7. Global Amphotericin B Injection Sales Market Share by Dosage Strength (2017-2022)
Table 8. Global Amphotericin B Injection Revenue by Dosage Strength (2017-2022) & ($ million)
Table 9. Global Amphotericin B Injection Revenue Market Share by Dosage Strength (2017-2022)
Table 10. Global Amphotericin B Injection Sale Price by Dosage Strength (2017-2022) & (US$/Vial)
Table 11. Global Amphotericin B Injection Sales by Application (2017-2022) & (Vial)
Table 12. Global Amphotericin B Injection Sales Market Share by Application (2017-2022)
Table 13. Global Amphotericin B Injection Revenue by Application (2017-2022)
Table 14. Global Amphotericin B Injection Revenue Market Share by Application (2017-2022)
Table 15. Global Amphotericin B Injection Sale Price by Application (2017-2022) & (US$/Vial)
Table 16. Global Amphotericin B Injection Sales by Company (2020-2022) & (Vial)
Table 17. Global Amphotericin B Injection Sales Market Share by Company (2020-2022)
Table 18. Global Amphotericin B Injection Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Amphotericin B Injection Revenue Market Share by Company (2020-2022)
Table 20. Global Amphotericin B Injection Sale Price by Company (2020-2022) & (US$/Vial)
Table 21. Key Manufacturers Amphotericin B Injection Producing Area Distribution and Sales Area
Table 22. Players Amphotericin B Injection Products Offered
Table 23. Amphotericin B Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Amphotericin B Injection Sales by Geographic Region (2017-2022) & (Vial)
Table 27. Global Amphotericin B Injection Sales Market Share Geographic Region (2017-2022)
Table 28. Global Amphotericin B Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Amphotericin B Injection Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Amphotericin B Injection Sales by Country/Region (2017-2022) & (Vial)
Table 31. Global Amphotericin B Injection Sales Market Share by Country/Region (2017-2022)
Table 32. Global Amphotericin B Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Amphotericin B Injection Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Amphotericin B Injection Sales by Country (2017-2022) & (Vial)
Table 35. Americas Amphotericin B Injection Sales Market Share by Country (2017-2022)
Table 36. Americas Amphotericin B Injection Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Amphotericin B Injection Revenue Market Share by Country (2017-2022)
Table 38. Americas Amphotericin B Injection Sales by Type (2017-2022) & (Vial)
Table 39. Americas Amphotericin B Injection Sales Market Share by Dosage Strength (2017-2022)
Table 40. Americas Amphotericin B Injection Sales by Application (2017-2022) & (Vial)
Table 41. Americas Amphotericin B Injection Sales Market Share by Application (2017-2022)
Table 42. APAC Amphotericin B Injection Sales by Region (2017-2022) & (Vial)
Table 43. APAC Amphotericin B Injection Sales Market Share by Region (2017-2022)
Table 44. APAC Amphotericin B Injection Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Amphotericin B Injection Revenue Market Share by Region (2017-2022)
Table 46. APAC Amphotericin B Injection Sales by Dosage Strength (2017-2022) & (Vial)
Table 47. APAC Amphotericin B Injection Sales Market Share by Dosage Strength (2017-2022)
Table 48. APAC Amphotericin B Injection Sales by Application (2017-2022) & (Vial)
Table 49. APAC Amphotericin B Injection Sales Market Share by Application (2017-2022)
Table 50. Europe Amphotericin B Injection Sales by Country (2017-2022) & (Vial)
Table 51. Europe Amphotericin B Injection Sales Market Share by Country (2017-2022)
Table 52. Europe Amphotericin B Injection Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Amphotericin B Injection Revenue Market Share by Country (2017-2022)
Table 54. Europe Amphotericin B Injection Sales by Type (2017-2022) & (Vial)
Table 55. Europe Amphotericin B Injection Sales Market Share by Dosage Strength (2017-2022)
Table 56. Europe Amphotericin B Injection Sales by Application (2017-2022) & (Vial)
Table 57. Europe Amphotericin B Injection Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Amphotericin B Injection Sales by Country (2017-2022) & (Vial)
Table 59. Middle East & Africa Amphotericin B Injection Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Amphotericin B Injection Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Amphotericin B Injection Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Amphotericin B Injection Sales by Dosage Strength (2017-2022) & (Vial)
Table 63. Middle East & Africa Amphotericin B Injection Sales Market Share by Dosage Strength (2017-2022)
Table 64. Middle East & Africa Amphotericin B Injection Sales by Application (2017-2022) & (Vial)
Table 65. Middle East & Africa Amphotericin B Injection Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Amphotericin B Injection
Table 67. Key Market Challenges & Risks of Amphotericin B Injection
Table 68. Key Industry Trends of Amphotericin B Injection
Table 69. Amphotericin B Injection Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Amphotericin B Injection Distributors List
Table 72. Amphotericin B Injection Customer List
Table 73. Global Amphotericin B Injection Sales Forecast by Region (2023-2028) & (Vial)
Table 74. Global Amphotericin B Injection Sales Market Forecast by Region
Table 75. Global Amphotericin B Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Amphotericin B Injection Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Amphotericin B Injection Sales Forecast by Country (2023-2028) & (Vial)
Table 78. Americas Amphotericin B Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Amphotericin B Injection Sales Forecast by Region (2023-2028) & (Vial)
Table 80. APAC Amphotericin B Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Amphotericin B Injection Sales Forecast by Country (2023-2028) & (Vial)
Table 82. Europe Amphotericin B Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Amphotericin B Injection Sales Forecast by Country (2023-2028) & (Vial)
Table 84. Middle East & Africa Amphotericin B Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Amphotericin B Injection Sales Forecast by Dosage Strength (2023-2028) & (Vial)
Table 86. Global Amphotericin B Injection Sales Market Share Forecast by Dosage Strength (2023-2028)
Table 87. Global Amphotericin B Injection Revenue Forecast by Dosage Strength (2023-2028) & ($ Millions)
Table 88. Global Amphotericin B Injection Revenue Market Share Forecast by Dosage Strength (2023-2028)
Table 89. Global Amphotericin B Injection Sales Forecast by Application (2023-2028) & (Vial)
Table 90. Global Amphotericin B Injection Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Amphotericin B Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Amphotericin B Injection Revenue Market Share Forecast by Application (2023-2028)
Table 93. Swiss Parenterals Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Swiss Parenterals Amphotericin B Injection Product Offered
Table 95. Swiss Parenterals Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 96. Swiss Parenterals Main Business
Table 97. Swiss Parenterals Latest Developments
Table 98. Aspen Pharmacare Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Aspen Pharmacare Amphotericin B Injection Product Offered
Table 100. Aspen Pharmacare Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 101. Aspen Pharmacare Main Business
Table 102. Aspen Pharmacare Latest Developments
Table 103. Health Biotech Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Health Biotech Amphotericin B Injection Product Offered
Table 105. Health Biotech Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 106. Health Biotech Main Business
Table 107. Health Biotech Latest Developments
Table 108. Abbott Laboratories Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Abbott Laboratories Amphotericin B Injection Product Offered
Table 110. Abbott Laboratories Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 111. Abbott Laboratories Main Business
Table 112. Abbott Laboratories Latest Developments
Table 113. Abraxis Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Abraxis Amphotericin B Injection Product Offered
Table 115. Abraxis Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 116. Abraxis Main Business
Table 117. Abraxis Latest Developments
Table 118. Astellas Pharma Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Astellas Pharma Amphotericin B Injection Product Offered
Table 120. Astellas Pharma Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 121. Astellas Pharma Main Business
Table 122. Astellas Pharma Latest Developments
Table 123. Bluepharma Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Bluepharma Amphotericin B Injection Product Offered
Table 125. Bluepharma Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 126. Bluepharma Main Business
Table 127. Bluepharma Latest Developments
Table 128. Bristol Myers Squibb Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Bristol Myers Squibb Amphotericin B Injection Product Offered
Table 130. Bristol Myers Squibb Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 131. Bristol Myers Squibb Main Business
Table 132. Bristol Myers Squibb Latest Developments
Table 133. Cheplapharm Arzneimittel Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Cheplapharm Arzneimittel Amphotericin B Injection Product Offered
Table 135. Cheplapharm Arzneimittel Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 136. Cheplapharm Arzneimittel Main Business
Table 137. Cheplapharm Arzneimittel Latest Developments
Table 138. Clinigen Group Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Clinigen Group Amphotericin B Injection Product Offered
Table 140. Clinigen Group Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 141. Clinigen Group Main Business
Table 142. Clinigen Group Latest Developments
Table 143. Flagship Biotech Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 144. Flagship Biotech Amphotericin B Injection Product Offered
Table 145. Flagship Biotech Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 146. Flagship Biotech Main Business
Table 147. Flagship Biotech Latest Developments
Table 148. Gilead Sciences Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 149. Gilead Sciences Amphotericin B Injection Product Offered
Table 150. Gilead Sciences Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 151. Gilead Sciences Main Business
Table 152. Gilead Sciences Latest Developments
Table 153. Ind Swift Laboratories Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 154. Ind Swift Laboratories Amphotericin B Injection Product Offered
Table 155. Ind Swift Laboratories Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 156. Ind Swift Laboratories Main Business
Table 157. Ind Swift Laboratories Latest Developments
Table 158. Kaliberr Labs Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 159. Kaliberr Labs Amphotericin B Injection Product Offered
Table 160. Kaliberr Labs Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 161. Kaliberr Labs Main Business
Table 162. Kaliberr Labs Latest Developments
Table 163. Kwality Pharmaceuticals Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 164. Kwality Pharmaceuticals Amphotericin B Injection Product Offered
Table 165. Kwality Pharmaceuticals Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 166. Kwality Pharmaceuticals Main Business
Table 167. Kwality Pharmaceuticals Latest Developments
Table 1. Amphotericin B Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Amphotericin B Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 5Mg/Vial
Table 4. Major Players of 50Mg/Vial
Table 5. Major Players of 100Mg/Vial
Table 6. Global Amphotericin B Injection Sales by Dosage Strength (2017-2022) & (Vial)
Table 7. Global Amphotericin B Injection Sales Market Share by Dosage Strength (2017-2022)
Table 8. Global Amphotericin B Injection Revenue by Dosage Strength (2017-2022) & ($ million)
Table 9. Global Amphotericin B Injection Revenue Market Share by Dosage Strength (2017-2022)
Table 10. Global Amphotericin B Injection Sale Price by Dosage Strength (2017-2022) & (US$/Vial)
Table 11. Global Amphotericin B Injection Sales by Application (2017-2022) & (Vial)
Table 12. Global Amphotericin B Injection Sales Market Share by Application (2017-2022)
Table 13. Global Amphotericin B Injection Revenue by Application (2017-2022)
Table 14. Global Amphotericin B Injection Revenue Market Share by Application (2017-2022)
Table 15. Global Amphotericin B Injection Sale Price by Application (2017-2022) & (US$/Vial)
Table 16. Global Amphotericin B Injection Sales by Company (2020-2022) & (Vial)
Table 17. Global Amphotericin B Injection Sales Market Share by Company (2020-2022)
Table 18. Global Amphotericin B Injection Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Amphotericin B Injection Revenue Market Share by Company (2020-2022)
Table 20. Global Amphotericin B Injection Sale Price by Company (2020-2022) & (US$/Vial)
Table 21. Key Manufacturers Amphotericin B Injection Producing Area Distribution and Sales Area
Table 22. Players Amphotericin B Injection Products Offered
Table 23. Amphotericin B Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Amphotericin B Injection Sales by Geographic Region (2017-2022) & (Vial)
Table 27. Global Amphotericin B Injection Sales Market Share Geographic Region (2017-2022)
Table 28. Global Amphotericin B Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Amphotericin B Injection Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Amphotericin B Injection Sales by Country/Region (2017-2022) & (Vial)
Table 31. Global Amphotericin B Injection Sales Market Share by Country/Region (2017-2022)
Table 32. Global Amphotericin B Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Amphotericin B Injection Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Amphotericin B Injection Sales by Country (2017-2022) & (Vial)
Table 35. Americas Amphotericin B Injection Sales Market Share by Country (2017-2022)
Table 36. Americas Amphotericin B Injection Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Amphotericin B Injection Revenue Market Share by Country (2017-2022)
Table 38. Americas Amphotericin B Injection Sales by Type (2017-2022) & (Vial)
Table 39. Americas Amphotericin B Injection Sales Market Share by Dosage Strength (2017-2022)
Table 40. Americas Amphotericin B Injection Sales by Application (2017-2022) & (Vial)
Table 41. Americas Amphotericin B Injection Sales Market Share by Application (2017-2022)
Table 42. APAC Amphotericin B Injection Sales by Region (2017-2022) & (Vial)
Table 43. APAC Amphotericin B Injection Sales Market Share by Region (2017-2022)
Table 44. APAC Amphotericin B Injection Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Amphotericin B Injection Revenue Market Share by Region (2017-2022)
Table 46. APAC Amphotericin B Injection Sales by Dosage Strength (2017-2022) & (Vial)
Table 47. APAC Amphotericin B Injection Sales Market Share by Dosage Strength (2017-2022)
Table 48. APAC Amphotericin B Injection Sales by Application (2017-2022) & (Vial)
Table 49. APAC Amphotericin B Injection Sales Market Share by Application (2017-2022)
Table 50. Europe Amphotericin B Injection Sales by Country (2017-2022) & (Vial)
Table 51. Europe Amphotericin B Injection Sales Market Share by Country (2017-2022)
Table 52. Europe Amphotericin B Injection Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Amphotericin B Injection Revenue Market Share by Country (2017-2022)
Table 54. Europe Amphotericin B Injection Sales by Type (2017-2022) & (Vial)
Table 55. Europe Amphotericin B Injection Sales Market Share by Dosage Strength (2017-2022)
Table 56. Europe Amphotericin B Injection Sales by Application (2017-2022) & (Vial)
Table 57. Europe Amphotericin B Injection Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Amphotericin B Injection Sales by Country (2017-2022) & (Vial)
Table 59. Middle East & Africa Amphotericin B Injection Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Amphotericin B Injection Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Amphotericin B Injection Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Amphotericin B Injection Sales by Dosage Strength (2017-2022) & (Vial)
Table 63. Middle East & Africa Amphotericin B Injection Sales Market Share by Dosage Strength (2017-2022)
Table 64. Middle East & Africa Amphotericin B Injection Sales by Application (2017-2022) & (Vial)
Table 65. Middle East & Africa Amphotericin B Injection Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Amphotericin B Injection
Table 67. Key Market Challenges & Risks of Amphotericin B Injection
Table 68. Key Industry Trends of Amphotericin B Injection
Table 69. Amphotericin B Injection Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Amphotericin B Injection Distributors List
Table 72. Amphotericin B Injection Customer List
Table 73. Global Amphotericin B Injection Sales Forecast by Region (2023-2028) & (Vial)
Table 74. Global Amphotericin B Injection Sales Market Forecast by Region
Table 75. Global Amphotericin B Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Amphotericin B Injection Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Amphotericin B Injection Sales Forecast by Country (2023-2028) & (Vial)
Table 78. Americas Amphotericin B Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Amphotericin B Injection Sales Forecast by Region (2023-2028) & (Vial)
Table 80. APAC Amphotericin B Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Amphotericin B Injection Sales Forecast by Country (2023-2028) & (Vial)
Table 82. Europe Amphotericin B Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Amphotericin B Injection Sales Forecast by Country (2023-2028) & (Vial)
Table 84. Middle East & Africa Amphotericin B Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Amphotericin B Injection Sales Forecast by Dosage Strength (2023-2028) & (Vial)
Table 86. Global Amphotericin B Injection Sales Market Share Forecast by Dosage Strength (2023-2028)
Table 87. Global Amphotericin B Injection Revenue Forecast by Dosage Strength (2023-2028) & ($ Millions)
Table 88. Global Amphotericin B Injection Revenue Market Share Forecast by Dosage Strength (2023-2028)
Table 89. Global Amphotericin B Injection Sales Forecast by Application (2023-2028) & (Vial)
Table 90. Global Amphotericin B Injection Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Amphotericin B Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Amphotericin B Injection Revenue Market Share Forecast by Application (2023-2028)
Table 93. Swiss Parenterals Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Swiss Parenterals Amphotericin B Injection Product Offered
Table 95. Swiss Parenterals Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 96. Swiss Parenterals Main Business
Table 97. Swiss Parenterals Latest Developments
Table 98. Aspen Pharmacare Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Aspen Pharmacare Amphotericin B Injection Product Offered
Table 100. Aspen Pharmacare Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 101. Aspen Pharmacare Main Business
Table 102. Aspen Pharmacare Latest Developments
Table 103. Health Biotech Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Health Biotech Amphotericin B Injection Product Offered
Table 105. Health Biotech Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 106. Health Biotech Main Business
Table 107. Health Biotech Latest Developments
Table 108. Abbott Laboratories Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Abbott Laboratories Amphotericin B Injection Product Offered
Table 110. Abbott Laboratories Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 111. Abbott Laboratories Main Business
Table 112. Abbott Laboratories Latest Developments
Table 113. Abraxis Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Abraxis Amphotericin B Injection Product Offered
Table 115. Abraxis Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 116. Abraxis Main Business
Table 117. Abraxis Latest Developments
Table 118. Astellas Pharma Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Astellas Pharma Amphotericin B Injection Product Offered
Table 120. Astellas Pharma Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 121. Astellas Pharma Main Business
Table 122. Astellas Pharma Latest Developments
Table 123. Bluepharma Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Bluepharma Amphotericin B Injection Product Offered
Table 125. Bluepharma Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 126. Bluepharma Main Business
Table 127. Bluepharma Latest Developments
Table 128. Bristol Myers Squibb Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Bristol Myers Squibb Amphotericin B Injection Product Offered
Table 130. Bristol Myers Squibb Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 131. Bristol Myers Squibb Main Business
Table 132. Bristol Myers Squibb Latest Developments
Table 133. Cheplapharm Arzneimittel Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Cheplapharm Arzneimittel Amphotericin B Injection Product Offered
Table 135. Cheplapharm Arzneimittel Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 136. Cheplapharm Arzneimittel Main Business
Table 137. Cheplapharm Arzneimittel Latest Developments
Table 138. Clinigen Group Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Clinigen Group Amphotericin B Injection Product Offered
Table 140. Clinigen Group Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 141. Clinigen Group Main Business
Table 142. Clinigen Group Latest Developments
Table 143. Flagship Biotech Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 144. Flagship Biotech Amphotericin B Injection Product Offered
Table 145. Flagship Biotech Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 146. Flagship Biotech Main Business
Table 147. Flagship Biotech Latest Developments
Table 148. Gilead Sciences Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 149. Gilead Sciences Amphotericin B Injection Product Offered
Table 150. Gilead Sciences Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 151. Gilead Sciences Main Business
Table 152. Gilead Sciences Latest Developments
Table 153. Ind Swift Laboratories Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 154. Ind Swift Laboratories Amphotericin B Injection Product Offered
Table 155. Ind Swift Laboratories Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 156. Ind Swift Laboratories Main Business
Table 157. Ind Swift Laboratories Latest Developments
Table 158. Kaliberr Labs Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 159. Kaliberr Labs Amphotericin B Injection Product Offered
Table 160. Kaliberr Labs Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 161. Kaliberr Labs Main Business
Table 162. Kaliberr Labs Latest Developments
Table 163. Kwality Pharmaceuticals Basic Information, Amphotericin B Injection Manufacturing Base, Sales Area and Its Competitors
Table 164. Kwality Pharmaceuticals Amphotericin B Injection Product Offered
Table 165. Kwality Pharmaceuticals Amphotericin B Injection Sales (Vial), Revenue ($ Million), Price (US$/Vial) and Gross Margin (2020-2022)
Table 166. Kwality Pharmaceuticals Main Business
Table 167. Kwality Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Amphotericin B Injection
Figure 2. Amphotericin B Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amphotericin B Injection Sales Growth Rate 2017-2028 (Vial)
Figure 7. Global Amphotericin B Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Amphotericin B Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 5Mg/Vial
Figure 10. Product Picture of 50Mg/Vial
Figure 11. Product Picture of 100Mg/Vial
Figure 12. Global Amphotericin B Injection Sales Market Share by Dosage Strength in 2021
Figure 13. Global Amphotericin B Injection Revenue Market Share by Dosage Strength (2017-2022)
Figure 14. Amphotericin B Injection Consumed in Hospital
Figure 15. Global Amphotericin B Injection Market: Hospital (2017-2022) & (Vial)
Figure 16. Amphotericin B Injection Consumed in Clinic
Figure 17. Global Amphotericin B Injection Market: Clinic (2017-2022) & (Vial)
Figure 18. Amphotericin B Injection Consumed in Other
Figure 19. Global Amphotericin B Injection Market: Other (2017-2022) & (Vial)
Figure 20. Global Amphotericin B Injection Sales Market Share by Application (2017-2022)
Figure 21. Global Amphotericin B Injection Revenue Market Share by Application in 2021
Figure 22. Amphotericin B Injection Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Amphotericin B Injection Revenue Market Share by Company in 2021
Figure 24. Global Amphotericin B Injection Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Amphotericin B Injection Revenue Market Share by Geographic Region in 2021
Figure 26. Global Amphotericin B Injection Sales Market Share by Region (2017-2022)
Figure 27. Global Amphotericin B Injection Revenue Market Share by Country/Region in 2021
Figure 28. Americas Amphotericin B Injection Sales 2017-2022 (Vial)
Figure 29. Americas Amphotericin B Injection Revenue 2017-2022 ($ Millions)
Figure 30. APAC Amphotericin B Injection Sales 2017-2022 (Vial)
Figure 31. APAC Amphotericin B Injection Revenue 2017-2022 ($ Millions)
Figure 32. Europe Amphotericin B Injection Sales 2017-2022 (Vial)
Figure 33. Europe Amphotericin B Injection Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Amphotericin B Injection Sales 2017-2022 (Vial)
Figure 35. Middle East & Africa Amphotericin B Injection Revenue 2017-2022 ($ Millions)
Figure 36. Americas Amphotericin B Injection Sales Market Share by Country in 2021
Figure 37. Americas Amphotericin B Injection Revenue Market Share by Country in 2021
Figure 38. United States Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Amphotericin B Injection Sales Market Share by Region in 2021
Figure 43. APAC Amphotericin B Injection Revenue Market Share by Regions in 2021
Figure 44. China Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Amphotericin B Injection Sales Market Share by Country in 2021
Figure 51. Europe Amphotericin B Injection Revenue Market Share by Country in 2021
Figure 52. Germany Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Amphotericin B Injection Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Amphotericin B Injection Revenue Market Share by Country in 2021
Figure 59. Egypt Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Amphotericin B Injection in 2021
Figure 65. Manufacturing Process Analysis of Amphotericin B Injection
Figure 66. Industry Chain Structure of Amphotericin B Injection
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 1. Picture of Amphotericin B Injection
Figure 2. Amphotericin B Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amphotericin B Injection Sales Growth Rate 2017-2028 (Vial)
Figure 7. Global Amphotericin B Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Amphotericin B Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 5Mg/Vial
Figure 10. Product Picture of 50Mg/Vial
Figure 11. Product Picture of 100Mg/Vial
Figure 12. Global Amphotericin B Injection Sales Market Share by Dosage Strength in 2021
Figure 13. Global Amphotericin B Injection Revenue Market Share by Dosage Strength (2017-2022)
Figure 14. Amphotericin B Injection Consumed in Hospital
Figure 15. Global Amphotericin B Injection Market: Hospital (2017-2022) & (Vial)
Figure 16. Amphotericin B Injection Consumed in Clinic
Figure 17. Global Amphotericin B Injection Market: Clinic (2017-2022) & (Vial)
Figure 18. Amphotericin B Injection Consumed in Other
Figure 19. Global Amphotericin B Injection Market: Other (2017-2022) & (Vial)
Figure 20. Global Amphotericin B Injection Sales Market Share by Application (2017-2022)
Figure 21. Global Amphotericin B Injection Revenue Market Share by Application in 2021
Figure 22. Amphotericin B Injection Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Amphotericin B Injection Revenue Market Share by Company in 2021
Figure 24. Global Amphotericin B Injection Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Amphotericin B Injection Revenue Market Share by Geographic Region in 2021
Figure 26. Global Amphotericin B Injection Sales Market Share by Region (2017-2022)
Figure 27. Global Amphotericin B Injection Revenue Market Share by Country/Region in 2021
Figure 28. Americas Amphotericin B Injection Sales 2017-2022 (Vial)
Figure 29. Americas Amphotericin B Injection Revenue 2017-2022 ($ Millions)
Figure 30. APAC Amphotericin B Injection Sales 2017-2022 (Vial)
Figure 31. APAC Amphotericin B Injection Revenue 2017-2022 ($ Millions)
Figure 32. Europe Amphotericin B Injection Sales 2017-2022 (Vial)
Figure 33. Europe Amphotericin B Injection Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Amphotericin B Injection Sales 2017-2022 (Vial)
Figure 35. Middle East & Africa Amphotericin B Injection Revenue 2017-2022 ($ Millions)
Figure 36. Americas Amphotericin B Injection Sales Market Share by Country in 2021
Figure 37. Americas Amphotericin B Injection Revenue Market Share by Country in 2021
Figure 38. United States Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Amphotericin B Injection Sales Market Share by Region in 2021
Figure 43. APAC Amphotericin B Injection Revenue Market Share by Regions in 2021
Figure 44. China Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Amphotericin B Injection Sales Market Share by Country in 2021
Figure 51. Europe Amphotericin B Injection Revenue Market Share by Country in 2021
Figure 52. Germany Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Amphotericin B Injection Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Amphotericin B Injection Revenue Market Share by Country in 2021
Figure 59. Egypt Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Amphotericin B Injection Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Amphotericin B Injection in 2021
Figure 65. Manufacturing Process Analysis of Amphotericin B Injection
Figure 66. Industry Chain Structure of Amphotericin B Injection
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
